Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure ...Middle East

-- After the pre-Phase III clinical trial meeting with Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) in June 2022, the pathway to the registration, including patient population, dose, treatment duration, etc. of ASC22 (Envafolimab) for...

Read More Details
Finally We wish PressBee provided you with enough information of ( Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure )

Also on site :

• Numbrix 9 - June 25
• Taylor Swift Stuns Fans With Unexpected Kane Brown Duet in Nashville: 'Unforgettable'
• 6/24: CBS Evening News